SCHEMBL3784958

SCHEMBL3784958

COc1ccc(N)cc1-c1ccc(N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.49
CHEK1 O14757 1/20 0.49
DAPK3 O43293 1/20 0.49
JAK2 O60674 1/20 0.49
ABL1 P00519 1/20 0.49
RET P07949 1/20 0.49
MET P08581 1/20 0.49
PIM1 P11309 1/20 0.49
MAP2K2 P36507 1/20 0.49
FLT3 P36888 1/20 0.49
MAPK8 P45983 1/20 0.49
GSK3A P49840 1/20 0.49
GSK3B P49841 1/20 0.49
RPS6KA3 P51812 1/20 0.49
LIMK1 P53667 1/20 0.49
TYRO3 Q06418 1/20 0.49
MAP4K2 Q12851 1/20 0.49
PRKAA1 Q13131 1/20 0.49
NTRK2 Q16620 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5841896 0.90 TDP1 (0.54) NTRK1ABL1ALDH1A1KDM4EUSP2
SCHEMBL23525668 0.89 ERN1 (0.48) NTRK1CHEK1DAPK3JAK2ABL1
SCHEMBL2185228 0.89 AGPAT2 (0.49) NTRK1ALDH1A1KDM4EUSP2MAPT
SCHEMBL5843621 0.89 FYN (0.46) NTRK1ALDH1A1KDM4EUSP2MAPT
SCHEMBL654302 0.88 PTGDR2 (0.57) NTRK1ALDH1A1KDM4EUSP2MAPT
SCHEMBL27185972 0.87 ALDH1A1 (0.55) ALDH1A1KDM4EUSP2MAPTGAA
Hydrochloric Acid SCHEMBL654301 0.86 PTGDR2 (0.55) NTRK1ALDH1A1KDM4EUSP2MAPT
SCHEMBL2783622 0.86 DHFR (0.55) NTRK1CHEK1DAPK3JAK2ABL1
SCHEMBL2784662 0.86 ALDH1A1 (0.55) NTRK1CHEK1DAPK3JAK2ABL1
SCHEMBL3841305 0.86 CYP19A1 (0.47) NTRK1CHEK1DAPK3JAK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 NTRK1 343/4885CHEK1 2077/4885DAPK3 2114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.